Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA hits Sanofi's struggling Lemtrada with new safety warning over reports of stroke, artery tears

fiercepharmaDecember 05, 2018

Tag: Drug safety , FDA , multiple sclerosis

PharmaSources Customer Service